{"id":372411,"title":"Notice - Release of guidance document: Regulatory framework for unauthorized new allergenic products of biological origin used for the diagnosis or treatment of allergic diseases - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T16:51:37.052000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/regulatory-framework-unauthorized-allergenic-products-biological-diagnosis-treatment-allergic-diseases.html","snippet":"Notice - Release of guidance document: Regulatory framework for unauthorized new allergenic products of biological origin used for the diagnosis or treatment of allergic diseases Date: November 13, 2012 (PDF Version - 175 K) Health Canada is pleased to announce the release of the…","rawSnapshotUrl":"/api/snapshots/raw/372411","browseUrl":"https://replay.healtharchive.ca/job-6/20260411165137/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/regulatory-framework-unauthorized-allergenic-products-biological-diagnosis-treatment-allergic-diseases.html#ha_snapshot=372411","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}